Stock abbreviation: 健康元
Stock code:600380
FORTHEHEALTH FORTHEFUTURE
为明天 为健康
Joincare Pharmaceutical Group Industry Co., Ltd.
lnterim Report 2022
【Mission】For the health, For the future
【Vision】Attentively Develop High-quality Medicines and lnnovative Medicines
【Core Values】Putting People at the first place, Valuing Workmanship and Quality,
Pursuing Innovation and lntegrity, Promoting Cooperation and Sharing
ImportantNotice
I The Board of Directors (the “Board”), the Board of Supervisors and directors, supervisors and senior management of the
Company hereby warrant the truthfulness, accuracy and completeness of the contents of the interim report (the “Report”),
and that there are no false representations, misleading statements or material omissions contained in the Report, and
severally and jointly accept responsibility.
II All the directors of the Company attended the Board meeting.
III The interim report of the Company is unaudited.
IV Mr. Zhu Baoguo (朱保国), the person-in-charge of the Company, and Mr. Qiu Qingfeng (邱庆丰), the person-in-charge
of the Company’s accounting work and the person-in-charge of the accounting department (the head of the accounting
department), declare that they hereby warrant the truthfulness, accuracy and completeness of the financial statements
contained in the Report.
V Profit distribution plan or plan for conversion of capital reserve to share capital approved by the Board during the
Reporting Period
Not applicable
VI Risk declaration for the forward-looking statements
√ Applicable □ N/A
The Report contains forward-looking statements which involve the future plans, development strategies, etc. of the
Company, yet do not constitute substantive undertakings of the Company to investors. Investors should exercise caution
prior to making investment decisions.
VII Whether there is non-operating use of funds by the controlling shareholder and their related parties
No
VIII Whether there is a violation of the prescribed decision-making procedures to provide external guarantees
No
IX Whether more than half of directors cannot warrant the truthfulness, accuracy and completeness of the Report disclosed
by the Company
No
X Significant risk warnings
There is no exceptionally significant risk that will have a material impact on the productions and operations of the
Company during the Reporting Period. The Company has described various risks related to productions and operations
that the Company may face and the corresponding response measures taken. Please refer to “Risks” in Chapter 3
“Management Discussion and Analysis”.
XI Others
□ Applicable √ N/A
XII The Report is prepared in both Chinese and English. In case of any discrepancies between two versions, the Chinese
version shall prevail.
FOR THE HEALTH FOR THE FUTURE
lnterimReport2022 1
Table of
Contents
Financial Highlights 2
Chapter 1 Definitions 4
Chapter 2 Company Profile and Major Financial Indicators 7
Chapter 3 Management Discussion and Analysis 12
Chapter 4 Corporate Governance 35
Chapter 5 EnvironmentalandCorporateSocialResponsibility 40
Chapter 6 Major Events 67
Chapter 7 Changes in Equity and Shareholders 82
Chapter 8 Information on Preferred Shares 87
Chapter 9 Information on Bonds 89
Chapter 10 Financial Statements 91
List of documents available The Financial Statements signed and sealed by the person-in-charge of
for inspection the Company, the person-in-charge of the Company’s accounting work
and the person-in-charge of the accounting department (the head of the
accounting department)
The original copies of all documents and announcements of the Company
which have been disclosed to the public on the website designated by
CSRC during the Reporting Period
FinancialHighlights
1. Major financial indicators (RMB100 million)
78.35 85.65
8.01 8.04
6.87
查看PDF原文
